Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.

Clinical trial NCT05338541 · UNKNOWN

Trial details

NCT number: NCT05338541
Sponsor: Yizhuo Zhang
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroblastoma in Children

Start date: 2022-05-27
Primary completion: 2024-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.